drugset / Trial / NCT02960113

Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

NCT02960113 ↗

Phase 4 Completed 240 enrolled Rutgers, The State University of New Jersey
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that receive just acupressure point P6 stimulation.

Timeline

Start
2016-05
Primary completion
2021-09
Completion
2021-09

Outcome

Missed primary endpoint

registry Scopolamine Patch vs Acupressure Point P6 vs Scopolamine Patch + Acupressure Point P6; p = 0.98; Chi-squared NCT02960113 ↗

registry Scopolamine Patch vs Acupressure Point P6 vs Scopolamine Patch + Acupressure Point P6; p = 0.90; Chi-squared NCT02960113 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Scopolamine Unknown — Other

Indications

No indication recorded.